含溶组织梭菌胶原酶胶原结合域的人碱性成纤维细胞生长因子复合冻干同种异体骨在大鼠腰椎后外侧融合术后对骨形成的影响
研究在大鼠双侧L4-L5后外侧融合模型中,比较冻干同种异体骨(FDBA)单独使用与复合bFGF-PKD-CBD融合蛋白对骨形成的影响。结果显示bFGF-PKD-CBD组移植骨体积及椎板和棘突表面新骨形成体积均显著高于对照组,组织学上新骨形成及周围软骨细胞和成纤维细胞更明显。作者认为FDBA复合bFGF-PKD-CBD可能是加速脊柱融合的有前景材料。
要点
- 大鼠腰椎后外侧融合模型中,FDBA复合bFGF-PKD-CBD组移植骨体积显著高于对照组。
- bFGF-PKD-CBD组椎板和棘突表面新骨形成体积显著高于对照组。
- 组织学上bFGF-PKD-CBD组新骨形成及周围软骨细胞和成纤维细胞明显。
核心结论
- FDBA复合bFGF-PKD-CBD可能是加速脊柱融合的有前景材料。
- 基于FDBA的bFGF-PKD-CBD局部递送系统可能为增强脊柱融合提供新的治疗途径。
研究设计与样本
- 实验研究,20只雄性Sprague-Dawley大鼠(每只200至250 g)随机分为两组,每组10只。
- 行双侧L4-L5后外侧融合,每侧使用150 mg FDBA粉末。
- FDBA分别与磷酸盐缓冲液(对照组)或0.58 nmol bFGF-PKD-CBD(bFGF-PKD-CBD组)孵育后用于融合手术。
- 采用X线片、微型计算机断层扫描和组织学(苏木精-伊红染色和von Kossa染色)评估效果。
主要发现
- bFGF-PKD-CBD组后外侧病灶移植骨体积显著高于对照组。
- bFGF-PKD-CBD组椎板和棘突表面新骨形成体积显著高于对照组。
- 组织学上bFGF-PKD-CBD组新骨形成及周围软骨细胞和成纤维细胞明显。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: An experimental study. OBJECTIVE: To evaluate the effectiveness of freeze-dried bone allograft (FDBA) with basic fibroblast growth factor (bFGF) fused with the polycystic kidney disease domain (PKD) and the collagen-binding domain (CBD) of Clostridium histolyticum collagenase, for the acceleration of lumbar posterolateral fusion in rats. SUMMARY OF BACKGROUND DATA: Reports indicate bFGF is an effective growth factor with osteogenic potential for promoting bone regeneration, although its efficiency decreases rapidly following its diffusion in body fluid from the host site. We developed a bFGF fusion protein containing the PKD and the CBD of C histolyticum collagenase (bFGF-PKD-CBD), which markedly enhanced bone formation at a relatively low concentration when applied to the surface of rat femurs in a previous study. The potential of this novel protein to accelerate bone fusion in a rat model of lumbar posterolateral fusion has yet to be investigated. METHODS: Bilateral L4-L5 posterolateral fusions were performed, using 150 mg of FDBA powder per side. A total of 20 male Sprague-Dawley rats weighing 200 to 250 g/each were divided into two groups of 10 rats: FDBA was incubated with either phosphate-buffered saline (control group) or 0.58 nmol bFGF-PKD-CBD (bFGF-PKD-CBD group) before fusion surgery. The effect of bFGF-PKD-CBD was estimated using radiographs, microcomputed tomography, and histology (hematoxylin-eosin and von Kossa staining). RESULTS: Both grafted bone volume in the posterolateral lesion and the volume of new bone formation on the surface of laminae and spinal processes were significantly higher in the bFGF-PKD-CBD group than in the control group. Histologically, new bone formation and surrounding chondrocytes and fibroblasts were prominent in the bFGF-PKD-CBD group. CONCLUSION: FDBA infused with bFGF-PKD-CBD may be a promising material for accelerating spinal fusion, and the FDBA-based delivery system for localizing bFGF-PKD-CBD may offer novel therapeutic approaches to augment spinal fusion. LEVEL OF EVIDENCE: N/A.
引用
- Inoue G, Uchida K, Matsushita O, et al. Effect of Freeze-Dried Allograft Bone With Human Basic Fibroblast Growth Factor Containing a Collagen-Binding Domain From Clostridium histolyticum Collagenase on Bone Formation After Lumbar Posterolateral Fusion Surgery in Rats. Spine (Phila Pa 1976). 2017. PMID: 28098745. doi:10.1097/BRS.0000000000002074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。